Alpha GPC + L-Theanine Supplement Manufacturer

The Alpha GPC + L-Theanine stack represents one of the most evidence-backed synergistic combinations in modern nootropic formulation. This is not a simple ingredient blend—it is a targeted cholinergic-gabaergic formula designed to support sustained cognitive output without overstimulation.

Synergistic Mechanism

Alpha GPC enhances cholinergic neurotransmission by serving as a direct precursor to acetylcholine (ACh), the primary neurotransmitter involved in learning, memory, and attentional control. Preclinical studies demonstrate that Alpha GPC increases ACh release in rat hippocampus slices following potassium stimulation, and partially counteracts scopolamine-induced depletion of brain ACh levels in the cortex and hippocampus.

L-Theanine promotes a state of calm attention by increasing alpha-wave generation (8–12 Hz) in the occipital and parietal regions, as demonstrated in multiple EEG studies. It does not sedate; rather, it shifts the brain toward a relaxed but alert state by enhancing GABA activity and attenuating cortisol response to mild stress.

The combination supports sustained focus without the overstimulation, jitter, or crash commonly associated with caffeine-based formulations. This makes it ideal for students, professionals, gamers, and aging populations seeking balanced cognitive enhancement.

Target Outcomes

• Focus Enhancement
• Memory Support
• Stress Reduction
• Mental Fatigue Reduction

This section summarizes peer-reviewed clinical evidence supporting the efficacy, safety, and mechanism of action for Alpha GPC and L-Theanine, both as standalone ingredients and in combination. All citations link to verifiable PubMed / PMC sources.

Alpha GPC — Evidence Summary

• Acetylcholine Precursor: Alpha GPC is a direct source of choline (41% by weight) that efficiently crosses the blood-brain barrier and is converted to free choline and then acetylcholine, supporting cholinergic neurotransmission.
• Cognitive Performance in Healthy Adults: A 2024 randomized, double-blind, placebo-controlled trial (NCT06690619) found that acute Alpha GPC supplementation (300 mg and 600 mg) significantly enhanced Stroop test performance—improving total scores and reducing completion times—in young, healthy males. The effect sizes were moderate (d = 0.48–0.61).
• Dementia and Cognitive Decline: A 2025 systematic review and meta-analysis (Frontiers in Neurology) compared choline alphoscerate (Alpha GPC) vs. citicoline across 3 RCTs (n=358). Alpha GPC demonstrated statistically significant improvements in overall clinical condition (SCAG global score: WMD -3.92, 95% CI: -7.41 to -0.42), cognitive function, interpersonal relationships, affective disorders, apathy, and somatic functioning compared to citicoline.
• Mechanism of Action: Preclinical studies show Alpha GPC reverses scopolamine-induced amnesia in rats and increases potassium-stimulated ACh release from hippocampal slices, confirming its role as a cholinergic enhancer in memory-critical brain regions.

L-Theanine — Evidence Summary

• Alpha Brain Wave Enhancement: EEG studies consistently demonstrate that L-Theanine (100–200 mg) increases alpha-wave power (8–12 Hz) in the occipital and parietal regions within 30–60 minutes of ingestion. This state is associated with relaxed alertness and selective attention without sedation.
• Stress and Cognitive Function: A 2019 randomized, placebo-controlled trial (n=104) found that 4 weeks of L-Theanine administration (200 mg/day) significantly reduced stress-related symptoms (depression, anxiety-trait, sleep disturbance) and improved cognitive function scores, including verbal fluency and executive function.
• Working Memory and Attention: A 2021 randomized placebo-controlled study in middle-aged and older subjects found that a single 100.6 mg dose of L-Theanine reduced reaction time in attention tasks and increased correct answers while decreasing omission errors in working memory tasks.
• Safety Profile: L-Theanine exhibits a favorable safety profile with good tolerability. No significant adverse events were reported in clinical trials at standard supplemental doses (50–250 mg/day).

Combination Benefits

While direct RCTs comparing Alpha GPC + L-Theanine as a fixed combination are limited, the mechanistic rationale is robust: Alpha GPC drives cholinergic signal (ACh-mediated attention and memory), while L-Theanine optimizes the noise-to-signal ratio (via alpha-wave-mediated filtering of distraction and stress-induced cognitive interference).

The result is a balanced nootropic effect: improved attention span, reduced cognitive fatigue, balanced mental energy, and enhanced productivity support—without the cardiovascular or anxiety side effects of stimulant-based alternatives.

Alpha GPC is commercially available in three primary assay grades: 50% powder (most common for capsules/tablets), 85% liquid (for beverages and liquid formulations), and 99% powder (purest grade, fully water-soluble, ideal for high-end positioning). Each grade has distinct physical properties, handling requirements, and cost profiles.

Grade A: Alpha GPC 50% Powder (Most Common)

Grade B: Alpha GPC 85% Liquid

Grade C: Alpha GPC 99% Powder (Premium Grade)

L-Theanine is commercially available in two primary purity grades: 98% (standard food-grade, most common for bulk formulations) and 99% (high-purity, preferred for premium and clinical-positioned products). Both grades are derived from green tea extract or fermentation processes. We also offer Suntheanine (patented enzymatic fermentation, >99% purity) for brands requiring proprietary positioning and additional trademark protection.

Grade A: L-Theanine 98% (Standard Food Grade)

Grade B: L-Theanine 99% (High-Purity / Premium Grade)

Grade C: L-Theanine Source Options

Quality Assurance Notes for Buyers

• Every incoming lot of Alpha GPC and L-Theanine is quarantined until identity verification (FTIR or HPLC against reference standard) and full COA review are completed.
• Heavy metals are screened by ICP-MS against USP <2232> elemental impurity limits for dietary supplements.
• Microbial testing follows USP <2021> (Total Aerobic Microbial Count) and USP <2022> (Specified Microorganisms).
• Residual solvents are quantified by headspace GC-FID per USP <467> guidelines.
• Stability data (24-month real-time and 6-month accelerated) is available for all grades to support shelf-life claims in finished products.
• Non-GMO, vegan, and allergen-free statements can be provided upon request for clean-label positioning.
• Suntheanine requires a trademark licensing agreement with Taiyo Kagaku for use on product labels and marketing materials.

KS Nutripharma provides end-to-end contract manufacturing services designed to de-risk your product launch and accelerate time-to-market. Every engagement includes dedicated project management, regulatory guidance, and quality assurance oversight.

OEM (Original Equipment Manufacturing)

You provide the formula; we manufacture to your exact specifications. Includes sourcing, production, testing, and packaging.

ODM (Original Design Manufacturing)

Our R&D team develops a custom formula based on your brief, target demographic, and price point. Full IP transfer upon completion.

Private Label

Choose from our library of proven formulations, rebrand with your logo and design, and launch in 4–6 weeks.

Custom Flavor Development

In-house flavorists develop masking and taste profiles for botanical ingredients. 50+ flavor options including natural fruit, mint, and exotic profiles.

Packaging Design

Full-service design team for label artwork, bottle selection, box design, and Amazon-compliant photography.

Stability Testing

Accelerated (40 degrees C / 75% RH) and real-time stability studies per ICH guidelines. Shelf-life claims supported by data.

Regulatory Documentation

FDA facility registration, NDI notification support, EU novel food assessments, COA compilation, allergen statements, and BSE/TSE certificates.

ur manufacturing process follows FDA 21 CFR Part 111 cGMP requirements from raw material receipt through finished product release. Every step is documented, validated, and subject to quality oversight to ensure consistent identity, purity, strength, and composition across every batch.

Step 1: Product Specification & Formulation Development

The process begins with a detailed product specification document defining label claim targets, serving size, allergen controls, contaminant limits, and packaging requirements. Our R&D team evaluates ingredient compatibility, excipient selection, taste-masking strategies, payload limits for each dosage form, and preliminary stability assumptions. For Alpha GPC + L-Theanine formulas, special attention is given to hygroscopicity control (Alpha GPC is moisture-sensitive) and flowability optimization to ensure uniform blending and accurate dosing.

Step 2: Supplier Qualification & Raw Material Procurement

All raw material suppliers are vetted through our approved vendor program. Each supplier must provide Certificates of Analysis (COAs), manufacturing licenses, and quality agreements. For Alpha GPC and L-Theanine, we require dual-source qualification to mitigate supply chain risk. Procurement includes supply continuity planning with 3-month safety stock maintained for critical ingredients.

Step 3: Incoming Quality Control (IQC) & Quarantine

Every lot of raw material is placed in quarantine upon receipt until full identity verification and testing are completed. IQC testing includes: (1) Identity confirmation by FTIR or HPLC against reference standards; (2) Potency assay (HPLC or titration); (3) Heavy metals screening by ICP-MS (Pb, As, Cd, Hg); (4) Microbial testing per USP <2021>/<2022>; (5) Residual solvent analysis by GC-FID; (6) Physical inspection (appearance, odor, particle size). Only materials passing all tests are released from quarantine for production use.

Step 4: Master Manufacturing Record (MMR) Preparation

Before production begins, a Master Manufacturing Record is generated for each batch. The MMR contains controlled instructions for: exact ingredient weights (including validated overages), target yields, equipment specifications, environmental conditions (temperature, humidity), blending parameters (time, speed, loading pattern), and in-process check points. The MMR is reviewed and approved by QA before batch execution.

Step 5: Weighing, Blending & Mixing

Ingredients are weighed on calibrated balances (precision ±0.01 g) in a climate-controlled weighing room (RH <45%, temperature 18–25°C). The blend is created in cGMP-compliant stainless steel equipment (V-blenders, ribbon blenders, or double-cone blenders depending on batch size and ingredient properties). Loading sequence follows validated procedures: excipients are loaded first, followed by actives, with intermediate blending steps to prevent segregation. Blend uniformity is verified by sampling at multiple points (top, middle, bottom) and analyzing by HPLC. For Alpha GPC formulations, nitrogen flushing is employed during blending to minimize oxidative degradation.

Step 6: Dosage Form Conversion

The uniform blend is converted into the final dosage form using validated equipment and procedures:

Capsules

High-speed encapsulation machines (up to 300,000 capsules/hour) fill gelatin or vegetable cellulose shells with precise powder weights. In-process weight checks every 30 minutes ensure dosing accuracy within ±5%.

Tablets

Rotary tablet presses (10-station to 45-station) compress the blend into tablets with consistent hardness, friability, and disintegration profiles. Coating (film, enteric, or sugar) is applied when required.

Gummies

Active ingredients are integrated into a gelatin or pectin base, deposited into molds, cooled, and demolded. Moisture content is controlled to <15% to prevent microbial growth and texture degradation.

Powders & Stick Packs

Blends are tested for flowability and particle size distribution before filling into jars, tubs, or single-serve sachets. Automated gravimetric feeders ensure ±1% fill accuracy.

Functional Beverages

Ingredients are dissolved or suspended in a liquid base under aseptic conditions, followed by pasteurization or UHT treatment, and filled into bottles or cans in a cleanroom environment.

Step 7: In-Process Quality Controls

Throughout manufacturing, in-process controls are performed at defined intervals: (1) Blend uniformity testing (HPLC assay of samples from multiple blender locations); (2) Weight variation checks (every 30 minutes for capsules/tablets; every 15 minutes for gummies); (3) Moisture analysis (Karl Fischer) for hygroscopic formulas; (4) Physical inspection (appearance, color, odor, texture); (5) Environmental monitoring (temperature, humidity, particle counts in cleanroom areas). Any deviation from specification triggers immediate investigation and corrective action before the batch proceeds.

Step 8: Finished Product Testing & COA Generation

Every finished batch undergoes comprehensive testing before release: (1) Identity verification by HPLC or FTIR for all active ingredients; (2) Potency assay against label claim (typically 100–105% of declared amount); (3) Purity testing: heavy metals (ICP-MS), residual solvents (GC-FID), pesticides (when applicable); (4) Microbial testing: total aerobic count, yeast/mold, E. coli, Salmonella, S. aureus per USP <2021>/<2022>; (5) Physical testing: disintegration time (tablets/capsules), hardness, friability, weight variation, moisture content; (6) Stability-indicating assays to confirm no degradation products exceed acceptance criteria. A Certificate of Analysis (COA) is generated for every batch and provided to the customer with each shipment.

Step 9: Packaging, Label Control & Lot Coding

Packaging operations are performed in a controlled environment with automated bottling, capping, and labeling lines. Label control procedures ensure the correct label version is used for each batch, with reconciliation of label counts to prevent mix-ups. Every bottle, box, and pallet is coded with a unique lot number, manufacturing date, and expiration date for full traceability. Tamper-evident seals and desiccant canisters are applied as specified. Visual inspection verifies label placement, legibility, and seal integrity.

Step 10: Quality Release & Distribution

The final step is QA disposition: a qualified quality assurance reviewer evaluates all batch records, test results, and deviation reports before approving the batch for release. Retain samples are stored under controlled conditions for the duration of the product shelf life plus one year. Released products are transferred to a climate-controlled warehouse (temperature 15–25°C, RH <60%) pending distribution. Complaint handling and recall readiness procedures are maintained to ensure rapid response if any post-market quality issue arises.

Manufacturing Process Summary

• Incoming Raw Material Testing: 100% identity verification by HPLC or FTIR for every lot of Alpha GPC and L-Theanine. Full heavy metal, microbial, and solvent residue screening.
• In-Process Controls: Weight checks, dissolution testing, and moisture analysis at defined intervals during production.
• Finished Product Testing: Every batch verified for potency, purity, disintegration time, and physical appearance before release.
• Stability Testing: Accelerated and real-time studies per ICH Q1A(R2) guidelines to support shelf-life claims.
• Third-Party Verification: Independent laboratory COA for every batch available upon request.
• Batch Traceability: Full lot tracking from raw material receipt through production, packaging, and distribution.

We maintain a comprehensive certification portfolio that satisfies the requirements of major global markets. Our quality management system is built on integrated layers: ISO 9001:2015 (quality management), GMP (production-floor baseline), FSSC 22000 Version 7 (food safety system certification, published May 2026, incorporating ISO 22002-x:2025 PRP standards), HACCP (preventive hazard control), and ISO 22000:2018 (management-system integrator). Our facility is FDA Registered for dietary supplement manufacturing.

We are not a trading company. We are a vertically integrated supplement OEM manufacturer with 19+ years of experience, 5 manufacturing bases, and the production scale to support both emerging brands and billion-unit global programs.

Manufacturing Scale & Infrastructure

Daily Production Capacity

Your Benefits: Whether you need a 50,000-unit pilot run or a 10-million-unit annual program, our 7 supplement lines and 5 manufacturing bases can scale without external bottlenecks.

Research & Development

Our R&D team works from concept to stability-tested prototype, including delayed-release coatings, liposomal delivery, and multi-botanical synergistic blends.

Global Reach & Brand Partnerships

We have shipped to 60+ countries across North America, Europe, Asia, the Middle East, and Australia. Our 500+ global brand partnerships range from startup DTC labels to multinational retailers.